The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, ...

Novartis (NVS) announced that the European Commission, EC, has approved Kisqali in combination with an aromatase inhibitor, AI, for the ...

Planegg/Martinsried, November 26, 2024.Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research ...

The Pacalis team is a blend of industry and academic expertise, led by co-founder and Monash university alumnus Dr David Bibby as Chief Executive Officer, and co-founder Professor Chris Langmead, ...

Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed away in August: “Lung ...

GLP-1 medications, which include Ozempic, Wegovy, Mounjaro and Zepbound, curb appetite and slow the digestion of food, so ...

After hours: November 27 at 6:38 PM EST Loading Chart for ICLR ...

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the ...

The best part about the run-up to Christmas is having an excuse to enjoy indulgent food and drink, carefully disguised in the ...

LPX-TI641, a therapy to promote immune system balance in MS and other autoimmune diseases, was assessed at varying doses in a ...

Over $49m in research funding has been awarded to 72 Monash University research projects in the latest Australian Research Council (ARC) Discovery Projects scheme. Research investigating safer AI, ...

Occasional smokers think the health warnings don’t apply to them, but the odd cigarette is more damaging than you think ...